Posts

Eli Lilly Acquires Centessa Pharmaceuticals for $6.3 Billion to Enter Sleep Disorder Market

Korsana Biosciences Goes Public Through Reverse Merger with Cyclerion Therapeutics

FDA Extends Orca Bio Orca-T Review Timeline Following Manufacturing Data Submission

Change in Orion Group Executive Team: Berkeley Vincent Appointed EVP of Innovative Medicines as of April 8, 2026

INOVIO Announces Proposed Public Offering - December 2024

Novo Nordisk to Cut 400 Jobs at Bloomington, Indiana Facility Amid Prior Ownership Layoffs

Eli Lilly's Orforglipron Obesity Pill Gains FDA Approval, Challenging Novo Nordisk's Wegovy

No Recent NICE Cardio Approval for Wegovy

Dual-Action Molecule and Drug Combos Show Promise in Treating Multiple Cancers in Mice Models

FDA Approves Eli Lilly's Oral GLP-1 Pill Foundayo (Orforglipron) as Response to Novo Nordisk

Ambrosia Raises $100M Series B to Develop Next-Generation Small Molecule GLP-1s

Ambrosia Biosciences Raises $100M Series B for Oral GLP-1 Drug Development

Merck Partners with Infinimmune on $838 Million Antibody Discovery Deal